Berkshire Grey Partners with AHS to Accelerate Next-Generation Warehouse Robotics for Fortune 100 eCommerce and 3PL Providers

A Media Snippet accompanying this release is available by clicking on the image or link below: Berkshire Grey Partners with AHS BEDFORD, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Berkshire Grey, Inc., (Nasdaq: BGRY), the leader in AI-enabled robotic solutions that automate supply chain processes, is partnering with Advanced Handling Systems (AHS), a leading system […]

F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, announced today that F-star will participate next week at the H. C. Wainwright 23rd Annual Global Investment Conference, taking place […]

Alchip Technology Sets Record Q2 Revenue And Operating Income

Taipei, Taiwan, Sept. 09, 2021 (GLOBE NEWSWIRE) — Taipei, Taiwan September 9, 2021 – Alchip Technologies’ 2021 second quarter financial results set records for revenue and net income.  This is the sixth consecutive quarter in which the company has reported record financial results.   Second quarter revenue was $97.4 million, up 77 percent from year-ago […]

SafeAI Releases First Operating System Purpose-Built for Autonomous Heavy Equipment

MILPITAS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — SafeAI, a global leader in autonomous heavy equipment, today announced the release of the SafeAI Autonomous Framework (SAF), the first operating system built specifically for autonomous heavy equipment. With the SAF, companies can leverage both SafeAI’s trusted infrastructure and industry expertise to accelerate their autonomous application development […]

Atos et Intigriti lancent un service de bug bounty intégré

Paris et Lille, le 9 septembre 2021 – Atos et Intigriti, première plateforme européenne de bug bounty et hacking éthique, annoncent leur collaboration pour proposer une offre de bug bounty de bout-en-bout à destination des entreprises. Le bug bounty consiste à solliciter des chercheurs en sécurité et hackers éthiques, sélectionnés selon un protocole précis, pour […]

Atos and Intigriti launch new integrated Bug Bounty service

Paris and Lille, France – September 9, 2021 – Atos and Intigriti, the European leading platform for bug bounty and ethical hacking, announce their collaboration to release an end-to-end bug bounty offering for organisations. Bug bounty consists of using expert researchers and ethical hackers, selected according to a precise protocol, to search for vulnerabilities in […]

Flo Announces $50 Million Series B Funding Round; Bringing Company to $800M Valuation

LONDON, Sept. 09, 2021 (GLOBE NEWSWIRE) — Flo, #1 OB-GYN-recommended app for period and cycle tracking1, today announced it closed $50M in a Series B financing, bringing the total capital raised to $65 million and company valuation to $800M. VNV Global and Target Global both led the round, with previous investments in Babylon Health, Lyft, […]

Green Hygienics Holdings Inc. (GRYN) to Become First Hemp Company to Develop ESG Report Using SASB Framework

SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Green Hygienics Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”), is pleased to be the first industrial hemp company in the U.S. to announce the publication of its annual Environmental, Social and Governance Report (“ESG Report”) using the Sustainability Accounting Standards Board (SASB) […]

Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline

LYON, France, and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, and PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (“PeptiDream”)(Tokyo: 4587), today announced that Amolyt Pharma has exercised its option to globally license a portfolio of macrocyclic peptide […]

Amolyt Pharma exerce l’option de licence sur un candidat médicament optimisé pour le traitement de l’acromégalie auprès de PeptiDream, étoffant ainsi son portefeuille de médicaments pour les maladies endocriniennes rares

LYON, France, et CAMBRIDGE, Mass., 09 sept. 2021 (GLOBE NEWSWIRE) — Amolyt Pharma, société internationale spécialisée dans le développement de peptides thérapeutiques ciblant les maladies endocriniennes rares, et PeptiDream Inc., entreprise biopharmaceutique basée à Kanagawa au Japon (« PeptiDream ») (Tokyo : 4587), ont annoncé aujourd’hui qu’Amolyt Pharma avait exercé son option de licence globale sur un portefeuille […]

Atos est désigné « Customers’ Choice 2021 » par le rapport Gartner Peer Insights dans la catégorie « Fournisseurs d’analyse de données »

Paris, le 9 septembre 2021 – Atos annonce aujourd’hui avoir été reconnu Choix des clients pour l’année 2021 (« Customers’ Choice 2021 ») par le rapport Gartner Peer Insights, dans la catégorie « Fournisseurs d’analyse de données » 1. Les distinctions « Customers’ Choice » de Gartner Peer Insights récompensent les fournisseurs et les produits qui ont été les mieux notés par leurs clients. Atos est fier de recueillir […]

Le Dr Benjamin Musher présidera l’étude de phase 1-2 évaluant le traitement anticancéreux Natrunix™ de XBiotech contre le cancer du pancréas

AUSTIN, Texas, 09 sept. 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ : XBIT) (« XBiotech ») a annoncé aujourd’hui que Benjamin Musher M.D. présidera le programme clinique de XBiotech sur le cancer du pancréas. La société développe actuellement un nouveau médicament contre le cancer, Natrunix™, qui sera utilisé en combinaison avec des agents anticancéreux cytotoxiques. Natrunix™ bloque spécifiquement une substance […]

Dr. Benjamin Musher wird Leiter der Phase-I/II-Studie zur Beurteilung von Natrunix™, der Anti-Tumor-Therapie von XBiotech bei Bauchspeicheldrüsenkrebs

AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) („XBiotech“) hat heute bekanntgegeben, dass Benjamin Musher M.D. das klinische Bauchspeicheldrüsenkrebs-Programm von XBiotech leiten wird. Das Unternehmen entwickelt derzeit ein neuartiges Krebsmedikament, Natrunix™, das in Kombination mit zytotoxischen Krebsmedikamenten verwendet werden soll. Natrunix™ blockiert gezielt eine Substanz, die nachweislich die Blutversorgung des Tumors anregt […]

Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies

WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies and Fc-fusion proteins. Named NGL-Impact® […]

A4BET® Announces 2021 Billion Dollar Global Domain & Trademark Auction

“Grandson of 1861 Black Tennessee slave seeks to break all-time record for domain & trademark sale” LOS ANGELES, Sept. 09, 2021 (GLOBE NEWSWIRE) — A4BET® is announcing a time sensitive auction to acquire this name. The sale of A4BET® includes: 1.) United States Patent & Trademark Office transfer ( 6th year renewal period ) 2.) domain 3.) […]

Lantronix xPico 250 IoT Gateway Enables Secure Connected Healthcare Applications

IRVINE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Internet of Things (IoT) and Remote Environment Management (REM) offering Software as a Service (SaaS), connectivity services, engineering services and intelligent hardware, provides IoT technologies that are driving the development of secure point-of-care (POC) […]

Institutional Investor Launches 2021 Developed Europe, 2021 Developed Europe Small & Midcap and 2021 Emerging EMEA Executive Team Rankings

LONDON, Sept. 09, 2021 (GLOBE NEWSWIRE) — Institutional Investor Research (II Research) surveys are the leading provider of independent performance validation and market sentiment across 8 global capital markets. Executive Team surveys are an independent platform for investment and sell-side professionals to evaluate credibility, communication, financial stewardship and capital allocation of corporate leadership, as well […]

A Post-hoc Analysis of Phase 3 Study Demonstrates Baseline Factors Associated with Visual Acuity and Anatomical Outcomes of Samsung Bioepis’ BYOOVIZ™ (Ranibizumab) in nAMD at the EURETINA 2021

The post-hoc analysis shows that baseline age, best corrected visual acuity (BCVA), central subfield thickness (CST), and total lesion size were identified to be associated with the visual acuity and anatomical outcomes when managing neovascular age-related macular degeneration (nAMD) with BYOOVIZ™ or reference ranibizumab, LUCENTIS®i  The subgroup analysis, based on associated baseline factors was conducted […]